Drugs / Depo-Medroxyprogesterone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1/2 | NCT00156650 Comparator | Dec 2004 → Jul 2005 | — | University of Washington | Completed | No outcome recorded |
| Phase 2/3 | NCT00490555 Comparator | Jan 2009 → Jan 2012 | — | University of Washington | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Depo-Medroxyprogesterone | “Depo-Medroxyprogesterone” NCT00156650 ↗ |
| Action | Inhibit | “DMPA suppresses LH and FSH” NCT00490555 ↗ |
| Route | Intramuscular | “depomedroxyprogesterone acetate (300 mg intramuscularly every 12 weeks)” PMID 17494097 ↗ May 2007 |